Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI)
The Lancet Regional Health - Americas (2022) - Comments
pubmed: 35308034  doi: 10.1016/j.lana.2022.100216  issn: 2667-193x 

Alice T.W. Song, Vanderson Rocha, Alfredo Mendrone-Júnior, Rodrigo T. Calado, Gil C. De Santis, Bruno D. Benites, Carolina Costa-Lima, Taiani Vargas, Leonardo S. Marques, Juliana C. Fernandes, Felipe C. Breda, Silvano Wendel, Roberta Fachini, Luiz V. Rizzo, José Mauro Kutner, Vivian I. Avelino-Silva, Rafael R.G. Machado, Edison L. Durigon, Sylvie Chevret, Esper G. Kallas